Detalles de la búsqueda
1.
Associations of Germline Genetic Variants With Depression and Fatigue Among Hematologic Cancer Patients Treated With Allogeneic Hematopoietic Cell Transplantation.
Psychosom Med
; 85(9): 813-819, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37678326
2.
Disability Related to Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 26(4): 772-777, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31669175
3.
Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 25(9): 1869-1874, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31085305
4.
The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index.
Biol Blood Marrow Transplant
; 25(12): 2468-2473, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31394265
5.
Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North America.
Biol Blood Marrow Transplant
; 25(3): 599-605, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30296479
6.
Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 25(1): 73-85, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30153491
7.
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(9): 1744-1755, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31158502
8.
Mismatched donor allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diverse patient populations.
Am J Hematol
; 99(6): 1196-1200, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38546371
9.
Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.
Biol Blood Marrow Transplant
; 21(1): 151-8, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25316109
10.
Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102.
JCO Oncol Pract
; 20(4): 572-580, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38261970
11.
Severity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy.
Transplant Cell Ther
; 30(1): 97.e1-97.e14, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37844687
12.
Frailty in Patients with Chronic Graft-versus-Host Disease.
Transplant Cell Ther
; 29(6): 367-374, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36921916
13.
Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry.
Transplant Cell Ther
; 29(10): 640.e1-640.e8, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37517612
14.
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial.
Transplant Cell Ther
; 29(3): 208.e1-208.e6, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36584941
15.
Maximally tolerated busulfan systemic exposure in combination with fludarabine as conditioning before allogeneic hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 18(7): 1099-107, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22198540
16.
Chronic Graft-versus-Host Disease, Nonrelapse Mortality, and Disease Relapse in Older versus Younger Adults Undergoing Matched Allogeneic Peripheral Blood Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.
Transplant Cell Ther
; 28(1): 34-42, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34637965
17.
A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease.
Blood Adv
; 6(1): 259-269, 2022 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34649279
18.
Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.
Transplant Cell Ther
; 28(10): 712.e1-712.e8, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35863740
19.
Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium.
Blood Adv
; 5(20): 4278-4284, 2021 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34521116
20.
A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation.
Blood Adv
; 5(5): 1154-1163, 2021 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33635333